Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system
Introduction
In the ageing population of industrialized nations, degenerative aortic stenosis is the most common native valve disorder. Surgical aortic valve replacement has excellent clinical outcomes but there is an increasing number of patients with severe aortic stenosis who are not considered surgical candidates, because of significant co-morbidity. In these patients catheter-based approaches for valve replacement show promising initial results [[1], [2], [3], [4], [5], [6], [7], [8]]. Fatal complications of TAVI like stroke, myocardial infarction, aortic dissection, cardiogenic shock or death are reported in up to 10% of patients [[9], [10], [11], [12], [13], [14]]. To date no powerful predictive clinical parameters or risk scores are known that would allow an individual risk stratification for procedural complications and long-term outcome [8]. Such predictors however would facilitate pre-procedural planning and would help to better compare the effectiveness of different devices and implantation strategies in various patient cohorts.
For the demanding TAVI procedure preinterventional anatomical information is mandatory for planning and proper device selection [[15], [16], [17], [18], [19]]. Multi Slice CT is increasingly used to determine dimensions of the aorta at different locations and may serve as an alternative to transthoracic and transesophageal echocardiography for assessing dimensions of the aortic annulus, which is critical for selection of the device size [20]. In addition to these parameters MSCT allows to accurately detect, localize and quantify aortic valve calcification and it has been demonstrated that the amount of aortic valve calcium is associated with unfavorable prognosis [21]. Due to the significant heterogeneity of amount and location of aortic valve calcification it may also influence the success of percutaneous valve implantation. In the present study we therefore sought to evaluate aortic valve calcification as a predictor for procedural complications and 1-year outcome after implantation of the CoreValve revalving system (CVRS).
Section snippets
Ethics statement
All patients gave written informed consent to be treated by that procedure and for preinterventional imaging. The local ethics committee of the chamber of physicians in Bavaria approved the protocol as a post procedure surveillance registry.
Patients
From June 2008 till August 2009 we recruited 69 consecutive patients suitable for transfemoral TAVI due to severe and symptomatic aortic stenosis. In an interdisciplinary conference consisting of cardiologists and cardiac surgeons all these patients were
Results
In the current study we included 69 consecutive patients who underwent transfemoral TAVI and preprocedural MSCT. Patient characteristics of the included patients are given in Table 1.
Based on the CT-measurements patients received either the 26 mm Device (n = 41) or the 29 mm device (n = 27).
Discussion
TAVI is a new therapy to treat severe aortic stenosis in patients with no option for surgery. In the first trials a remarkable success rate and an impressive survival rate was demonstrated [7]. Although parameters predicting procedural risk and mortality would be very helpful for improved patient selection, powerful predictors or prediction models are not well known yet. Surgical risk scores like the log Euro score or the STS-score are suitable for selecting candidates for TAVI, they failed
Acknowledgments
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.
References (35)
- et al.
Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis
Arch Cardiovasc Dis
(2010) - et al.
Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation
Am J Cardiol
(2010) - et al.
The impact of percutaneous implantation of aortic valve prosthesis in the treatment of severe aortic stenosis
Int J Cardiol
(2011) - et al.
Multimodality quantitative imaging of aortic root for transcatheter aortic valve implantation: more complex than it appears
J Am Coll Cardiol
(2010) - et al.
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation
J Am Coll Cardiol
(2010) - et al.
Relation of aortic valve calcium detected by cardiac computed tomography to all-cause mortality
Am J Cardiol
(2010) - et al.
Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system—a Bern–Rotterdam Study
Am Heart J
(2010) - et al.
Relationship of aortic valve calcification with coronary artery calcium severity: the Multi-Ethnic Study of Atherosclerosis (MESA)
J Cardiovasc Comput Tomogr
(2010) - et al.
Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA)
Am J Cardiol
(2010) - et al.
Can total cardiac calcium predict the coronary calcium score?
Int J Cardiol
(2011)
Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure
JACC Cardiovasc Interv
Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis
JACC Cardiovasc Interv
Mechanisms, treatment and course of paravalvular aortic regurgitation after percutaneous implantation of the CoreValve aortic prosthesis
Int J Cardiol
Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation
Int J Cardiol
Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study
Circulation
Transcatheter aortic valve implantation: predictors of procedural success—the Siegburg–Bern experience
Eur Heart J
Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction
Circulation
Cited by (78)
Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement Patients
2022, Journal of the Society for Cardiovascular Angiography and InterventionsRisk factors for paravalvular leak after transcatheter aortic valve replacement
2019, Journal of Thoracic and Cardiovascular SurgeryAn in vitro model quantifying the effect of calcification on the tissue–stent interaction in a stenosed aortic root
2019, Journal of Biomechanics
- 1
AW. Leber and M. Kasel contributed equally to the study.